Clinical Trial Update: Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating botulinum toxin A for chronic postsurgical pain after lung cancer surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Pain Neuropathic
• Pain Postoperative
• Post-thoracotomy Pain Syndrome

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Allan Vestergaard Danielsen, MD | Conditions: Chronic Pain, Post-thoracotomy Pain Syndrome | Phase 1, Phase 2 | Status: UNKNOWN